Envestnet Asset Management Inc Alnylam Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

$326 Billion
Q2 2025

A detailed history of Envestnet Asset Management Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 95,796 shares of ALNY stock, worth $46.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

95,796

Previous 72,047 32.96%

Holding current value

$46.1 Million

Previous $19.5 Million 60.57%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$224.32 - $326.09 $5.33 Million - $7.74 Million	23,749 Added 32.96%	95,796 $31.2 Million
Q1 2025 Apr 29, 2025	BUY	$233.07 - $290.7 $1.41 Million - $1.75 Million	6,033 Added 9.14%	72,047 $19.5 Million
Q4 2024 Feb 12, 2025	BUY	$232.27 - $300.43 $8.05 Million - $10.4 Million	34,647 Added 110.46%	66,014 $15.5 Million
Q3 2024 Nov 06, 2024	BUY	$233.81 - $287.01 $1.46 Million - $1.79 Million	6,227 Added 24.77%	31,367 $8.63 Million
Q2 2024 Aug 08, 2024	SELL	$143.31 - $247.0 $328,896 - $566,865	-2,295 Reduced 8.37%	25,140 $6.11 Million
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $22,855 - $30,919	156 Added 0.57%	27,435 $4.1 Million
Q4 2023 Feb 13, 2024	BUY	$151.41 - $196.57 $410,169 - $532,508	2,709 Added 11.03%	27,279 $5.22 Million
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $977,999 - $1.21 Million	5,727 Added 30.39%	24,570 $4.35 Million
Q2 2023 Aug 04, 2023	BUY	$185.01 - $212.05 $643,279 - $737,297	3,477 Added 22.63%	18,843 $3.58 Million
Q1 2023 May 11, 2023	BUY	$182.66 - $235.53 $233,804 - $301,478	1,280 Added 9.09%	15,366 $3.08 Million
Q4 2022 Feb 07, 2023	SELL	$185.53 - $241.31 $556,590 - $723,930	-3,000 Reduced 17.56%	14,086 $3.35 Million
Q3 2022 Nov 10, 2022	BUY	$138.54 - $232.0 $411,740 - $689,504	2,972 Added 21.06%	17,086 $3.42 Million
Q2 2022 Aug 03, 2022	SELL	$120.42 - $169.29 $2.08 Million - $2.93 Million	-17,306 Reduced 55.08%	14,114 $2.06 Million
Q1 2022 May 04, 2022	SELL	$127.18 - $173.91 $367,931 - $503,121	-2,893 Reduced 8.43%	31,420 $5.13 Million
Q4 2021 Feb 04, 2022	BUY	$159.56 - $209.29 $451,235 - $591,872	2,828 Added 8.98%	34,313 $5.82 Million
Q3 2021 Oct 07, 2021	BUY	$169.75 - $207.73 $251,230 - $307,440	1,480 Added 4.93%	31,485 $5.94 Million
Q2 2021 Aug 04, 2021	BUY	$128.63 - $176.89 $434,512 - $597,534	3,378 Added 12.69%	30,005 $5.09 Million
Q1 2021 May 04, 2021	BUY	$126.83 - $175.69 $1.65 Million - $2.28 Million	12,998 Added 95.37%	26,627 $3.76 Million
Q4 2020 Feb 02, 2021	SELL	$122.97 - $147.0 $3.07 Million - $3.67 Million	-24,953 Reduced 64.68%	13,629 $1.77 Million
Q3 2020 Oct 09, 2020	SELL	$121.19 - $165.49 $213,052 - $290,931	-1,758 Reduced 4.36%	38,582 $5.62 Million
Q2 2020 Jul 08, 2020	BUY	$104.21 - $156.44 $3.33 Million - $5 Million	31,940 Added 380.24%	40,340 $5.98 Million
Q1 2020 Apr 23, 2020	BUY	$93.12 - $133.99 $782,208 - $1.13 Million	8,400 New	8,400 $914,000

Others Institutions Holding ALNY

# of Institutions

763

Shares Held

115M

Call Options Held

584K

Put Options Held

661K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $59.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Alnylam Pharmaceuticals, Inc. Transaction History